Overexpression of farnesyl pyrophosphate synthase increases myocardial ischemia/reperfusion injury in mice

被引:4
作者
Dai, Dongpu [1 ]
Sun, Xiaotong [1 ]
Ding, Jie [1 ]
Chen, Yuxiao [1 ]
Hu, Shenjiang [1 ]
机构
[1] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Inst Cardiol, 79 Qing Chun Rd, Hangzhou 310003, Zhejiang, Peoples R China
关键词
Reactive oxygen species; Rac1; Langendorff; REPERFUSION INJURY; FREE-RADICALS; IN-VIVO; RAC1; INHIBITION; PROTECTION; OXIDASE; LIVER; HEART; MECHANISMS;
D O I
10.1016/j.gene.2018.05.116
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Famesyl pyrophosphate synthase (FPPS) is a vital enzyme in the mevalonate pathway. Our previous study has indicated that overexpression of FPPS increases hypoxia/reoxygenation (HR) injury in Heart-derived H9c2 Cells. Hence, we designed this experiment to further investigate the effect of FPPS on myocardial ischemia/reperfusion (MIR) injury using a transgenic (Tg) model, and explore the relevant mechanisms. The results showed that when mouse hearts were subjected to ex vivo I/R, Tg mice have a higher CK and LDH, a larger myocardial infarct size and lower heart function recovery. These phenomena are associated with the increased Rac1 activity and ROS generation. These findings point to that FPPS might be a potential target in preventing MIR in vivo.
引用
收藏
页码:72 / 78
页数:7
相关论文
共 34 条
[1]   INFLUENCE OF OXYGEN-DERIVED FREE-RADICAL SCAVENGERS ON ISCHEMIC LIVERS [J].
ATALLA, SL ;
TOLEDOPEREYRA, LH ;
MACKENZIE, GH ;
CEDERNA, JP .
TRANSPLANTATION, 1985, 40 (06) :584-590
[2]   MYOCARDIAL REPERFUSION - A DOUBLE-EDGED SWORD [J].
BRAUNWALD, E ;
KLONER, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (05) :1713-1719
[3]   Mevalonate pathway: A review of clinical and therapeutical implications [J].
Buhaescu, Irina ;
Izzedine, Hassane .
CLINICAL BIOCHEMISTRY, 2007, 40 (9-10) :575-584
[4]   Role of oxidants in ischemic brain damage [J].
Chan, PH .
STROKE, 1996, 27 (06) :1124-1129
[5]   Knock-down of farnesyl pyrophosphate synthase protects heart-derived H9c2 cells against hypoxia/reoxygenation-induced injury [J].
Dai, Dongpu ;
Wu, Huandong ;
Yang, Jian ;
Shen, Shizhen ;
Zhao, Chenze ;
Ding, Jie ;
Hu, Shenjiang .
CELL BIOLOGY INTERNATIONAL, 2017, 41 (09) :982-990
[7]   Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning [J].
Ferdinandy, Peter ;
Schulz, Rainer ;
Baxter, Gary F. .
PHARMACOLOGICAL REVIEWS, 2007, 59 (04) :418-458
[8]   Ischemic stroke and incomplete infarction [J].
Garcia, JH ;
Lassen, NA ;
Weiller, C ;
Sperling, B ;
Nakagawara, J .
STROKE, 1996, 27 (04) :761-765
[9]   ROS and NADPH oxidase: key regulators of tumor vascularisation [J].
Garrido-Urbani, Sarah ;
Jaquet, Vincent ;
Imhof, Beat A. .
M S-MEDECINE SCIENCES, 2014, 30 (04) :415-421
[10]   Current issues in reperfusion therapy [J].
Gersh, BJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (8B) :3P-11P